IEZZI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 5.858
EU - Europa 4.171
AS - Asia 3.755
SA - Sud America 572
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
Totale 14.437
Nazione #
US - Stati Uniti d'America 5.747
SG - Singapore 1.439
CN - Cina 1.154
IT - Italia 812
IE - Irlanda 709
UA - Ucraina 606
SE - Svezia 493
BR - Brasile 488
TR - Turchia 485
GB - Regno Unito 433
DE - Germania 330
IN - India 300
FR - Francia 280
VN - Vietnam 174
FI - Finlandia 157
RU - Federazione Russa 114
CA - Canada 67
NL - Olanda 49
CZ - Repubblica Ceca 39
AR - Argentina 38
PL - Polonia 38
HK - Hong Kong 37
ZA - Sudafrica 32
BE - Belgio 29
MX - Messico 25
AT - Austria 23
ES - Italia 23
BD - Bangladesh 22
KR - Corea 20
JP - Giappone 19
IQ - Iraq 17
IR - Iran 16
EU - Europa 12
EC - Ecuador 11
VE - Venezuela 11
IL - Israele 10
MA - Marocco 10
PK - Pakistan 10
ID - Indonesia 9
AE - Emirati Arabi Uniti 7
GR - Grecia 7
CL - Cile 6
CO - Colombia 6
OM - Oman 6
RO - Romania 6
SA - Arabia Saudita 6
AU - Australia 5
CH - Svizzera 5
KE - Kenya 5
LT - Lituania 5
BZ - Belize 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
TN - Tunisia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
LK - Sri Lanka 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.437
Città #
Singapore 1.062
Chandler 896
Jacksonville 704
Dublin 699
Beijing 346
Ashburn 335
Princeton 300
Dallas 287
Southend 286
Dearborn 233
Izmir 225
Nanjing 188
New York 163
Ann Arbor 155
Santa Clara 144
Los Angeles 137
Altamura 134
Wilmington 134
Chieti 121
The Dalles 112
Cambridge 111
Boardman 98
Pescara 98
Tongling 78
Buffalo 64
Nanchang 63
Munich 62
Ho Chi Minh City 60
Redondo Beach 56
São Paulo 55
Woodbridge 50
Helsinki 36
Hong Kong 36
Brooklyn 34
Hebei 34
Grevenbroich 33
Warsaw 32
Dong Ket 31
Tianjin 31
Washington 31
Nuremberg 30
Rome 30
Denver 29
Shenyang 29
Brno 28
Seattle 28
Hanoi 26
Hefei 26
Johannesburg 26
Montreal 26
London 25
Chennai 24
Kunming 24
Brussels 23
Houston 23
Norwalk 23
Atlanta 21
Changsha 21
Chicago 21
Frankfurt am Main 21
Ancona 20
Milan 20
Seoul 20
Turku 19
Jiaxing 18
Rio de Janeiro 18
Tokyo 18
Amsterdam 17
Ankara 17
Augusta 17
Castignano 16
Hangzhou 16
Jinan 16
San Mateo 16
Stockholm 16
Toronto 16
Boston 15
Orem 15
Poplar 15
Manchester 14
Orange 14
Vienna 14
Falls Church 13
Camerino 12
Mexico City 12
Mumbai 12
Pune 12
Belo Horizonte 11
Guangzhou 11
Leawood 11
San Francisco 11
Ascoli Piceno 10
Curitiba 10
Phoenix 10
Ardabil 9
Bologna 9
Changchun 9
Charlotte 9
Lanzhou 9
Lappeenranta 9
Totale 8.814
Nome #
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 179
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 172
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 149
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 148
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 147
L’allergoide monomerico agisce anche sul GALT 142
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 139
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 134
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 134
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 132
Anti-Thyroid Effect of Resveratrol 132
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 131
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 130
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 127
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 127
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 125
null 125
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 124
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 124
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 124
Resveratrol has anti-thyroid effects both in vitro and in vivo 124
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 123
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 121
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 121
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 120
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 120
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 119
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 119
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 118
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 118
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 117
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 117
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 116
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 116
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 116
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 113
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 113
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 113
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 113
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 113
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 112
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 112
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 112
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 112
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 112
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 111
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 111
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 111
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 111
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 110
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 109
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 109
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 106
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 106
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 106
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 106
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 105
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 105
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 104
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 103
Antimetastatic activity of a preventive cancer vaccine. 102
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 102
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 101
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 101
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 100
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 100
Neutrophils in anti-cancer immunological strategies: old players in new games 99
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 99
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 98
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 98
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 97
rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant. 97
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 96
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 95
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 94
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 94
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 94
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 94
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 93
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 93
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 93
Stem Cell Emergence After HBO In Volunteers 93
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 93
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 93
p130Cas is an essential transducer element in ErbB2 transformation. 92
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 91
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 91
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 91
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 90
Phospholipase Cgamma1 is required for metastasis development and progression 90
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 90
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 89
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 89
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 89
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 88
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 88
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 88
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects. 87
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. 86
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 86
Totale 11.012
Categoria #
all - tutte 62.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021530 0 0 0 0 0 165 27 10 58 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.929 173 490 388 102 94 136 205 194 294 130 325 398
2025/20262.856 491 257 574 786 651 97 0 0 0 0 0 0
Totale 14.999